BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12867117)

  • 1. Non-Hodgkin lymphoma.
    Evans LS; Hancock BW
    Lancet; 2003 Jul; 362(9378):139-46. PubMed ID: 12867117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of non-Hodgkin's lymphoma: biology, staging, and treatment.
    Fisher RI
    Semin Oncol; 2003 Apr; 30(2 Suppl 4):3-9. PubMed ID: 12728402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy in Hodgkin disease and non-Hodgkin lymphomas].
    Sréter L
    Orv Hetil; 2009 Apr; 150(14):651-5. PubMed ID: 19318337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-Hodgkin lymphomas. New histological, cytological and prognostic correlations (author's transl)].
    Hérait P; Gérard-Marchant R; Amiel JL; Caillaud JM; Tursz T; Droz JP
    Nouv Presse Med; 1981 Jun; 10(27):2267-71. PubMed ID: 7022369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The progress in treatment for malignant lymphomas and the future direction].
    Munakata W; Tobinai K
    Nihon Rinsho; 2014 Mar; 72(3):399-405. PubMed ID: 24724394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in indolent and aggressive lymphomas and its influence on disease outcome.
    Zodelava M; Betaneli M; Tsartsidze E; Kharabadze M
    Georgian Med News; 2009 Feb; (167):32-6. PubMed ID: 19276466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphoma: the old and the new.
    Cabanillas F
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S87-90. PubMed ID: 22035756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and outcomes of primary breast lymphoma.
    Caon J; Wai ES; Hart J; Alexander C; Truong PT; Sehn LH; Connors JM
    Clin Breast Cancer; 2012 Dec; 12(6):412-9. PubMed ID: 23018097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin's lymphoma of the sino-nasal tract in children.
    Zagolski O; Dwivedi RC; Subramanian S; Kazi R
    J Cancer Res Ther; 2010; 6(1):5-10. PubMed ID: 20479539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medicinal therapy of malignant lymphomas].
    Aul C; Schroeder M; Giagounidis A
    Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factors and predictive model of non-Hodgkin's lymphoma: pathological prognostic groupings and international prognostic index].
    Shimoyama M
    Nihon Rinsho; 2000 Mar; 58(3):602-11. PubMed ID: 10741132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Hodgkin lymphoma: diagnosis and treatment.
    Ansell SM; Armitage J
    Mayo Clin Proc; 2005 Aug; 80(8):1087-97. PubMed ID: 16092591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of primary endocrine non-Hodgkin lymphomas: does the site make the difference?
    Hatjiharissi E; Diamantidis MD; Papaioannou M; Dimou T; Chrisoulidou A; Patakiouta F; Constantinou N; Pazaitou-Panayiotou K
    QJM; 2013 Jul; 106(7):623-30. PubMed ID: 23426729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of non-Hodgkin lymphomas arising at extranodal sites.
    Zucca E; Gregorini A; Cavalli F
    Ther Umsch; 2010 Oct; 67(10):517-25. PubMed ID: 20886458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment options in non-Hodgkin lymphomas].
    Tilly H
    Rev Prat; 2010 Jan; 60(1):69-74. PubMed ID: 20222315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the management of non-Hodgkin's lymphomas.
    Gaynor ER; Fisher RI
    Dis Mon; 1989 Sep; 35(9):597-650. PubMed ID: 2676434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
    Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
    Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Hodgkin lymphoma.
    Shankland KR; Armitage JO; Hancock BW
    Lancet; 2012 Sep; 380(9844):848-57. PubMed ID: 22835603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.